The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings: evidence from Germany

BACKGROUND: Antigen-based rapid diagnostic tests (Ag-RDT) have been implemented in hospitals and nursing homes to screen for infectious individuals without symptoms suggestive of SARS-CoV-2 infections and to prevent entry into these high-risk settings. Despite their benefits for screening, the cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurtado, Alfonso Valenzuela, Nguyen, Hoa Thi, Schenkel, Viktoria, Wachinger, Jonas, Seybold, Joachim, Denkinger, Claudia M., De Allegri, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845412/
https://www.ncbi.nlm.nih.gov/pubmed/35157154
http://dx.doi.org/10.1186/s13561-022-00361-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845412/
https://www.ncbi.nlm.nih.gov/pubmed/35157154
http://dx.doi.org/10.1186/s13561-022-00361-3

Ejemplares similares